ABSTRACT:
Background: Safe and effective treatment relies upon patients being well informed and educated about their medications. The proper use of drugs and patient education are vital for the management of chronic diseases especially asthma. Developing the patient’s knowledge regarding their therapy is the key component in asthma management. This study was designed to check the impact of clinical pharmacist mediated counselling on quality of life (QoL) of asthma patients. Methodology: This study was carried out in a tertiary care hospital to assess the impact of clinical pharmacist mediated patient counselling on the QoL of asthma patients using the SF-36 questionnaire. In this study, a total of a hundred patients diagnosed with asthma were enrolled by considering the inclusion and exclusion criteria. Out of this, half of the patients were segregated to intervention and control groups. Results: The study identified fumes and smoking (30%) as the major environmental trigger for asthma especially in males (50%) and it was found to be the major risk factor in males. After clinical pharmacist-led counselling, the intervention group showed improvement in QoL from baseline to 1st and 2nd follow-ups in comparison with the control group. Physical activity and quality of life-related to day to day activity was also found to be increased during the second follow-up in the intervention group than in the control group (P<0.01). Conclusion: Our study concluded that continuous education programs and counselling should be conducted for asthma patients to emphasize and re-emphasize the importance of QoL, to prevent recurrences, reduce the progression of the disease and ultimately minimize the hospitalization and there is a need of continuous pharmaceutical care services/monitoring to improve the better quality of life.
Cite this article:
Linu Mohan P, Reshma Surendran, Shihas Azeez, Abel C. Mathew. Effectiveness of Clinical pharmacist mediated educational intervention on quality of life of Indian asthmatics. Research J. Pharm. and Tech 2020; 13(3): 1435-1440. doi: 10.5958/0974-360X.2020.00262.0
Cite(Electronic):
Linu Mohan P, Reshma Surendran, Shihas Azeez, Abel C. Mathew. Effectiveness of Clinical pharmacist mediated educational intervention on quality of life of Indian asthmatics. Research J. Pharm. and Tech 2020; 13(3): 1435-1440. doi: 10.5958/0974-360X.2020.00262.0 Available on: https://rjptonline.org/AbstractView.aspx?PID=2020-13-3-67
REFERENCES:
1.
Naveen MR,
Santhosh YL. Asthma: An Overview. Research J. Pharm. and Tech. 2011; 4(6): 883-90
2.
P. Geetha, M.
Kousalya, S. Geetha Lakshmi, R. Gopi. Prescribing Pattern of Drugs Used For
Respiratory Disease in Pediatric Patients at Private Hospital. Research J. Pharm.
and Tech. 2016; 9(3):251-56.
3.
H. William Kelly
and Christine A. Sorkness; Asthma; Joseph T Dipiro, Pharmacotherapy; a
Pathophysiologic approach. VII edition 2008; 463- 94
4.
Kabila B, Sankar
V- Risk factor assessment Study for Bronchial Asthma among The Rural People. Indian
Journal of Pharmacy Practice 2011;
4(3):51-56
5.
World health
organization. Global surveillance, prevention and control of chronic
respiratory diseases: a comprehensive approach, 2007
6.
Peter J. Barnes. Asthma. In: Harrison's
Principles of Internal Medicine. 17th ed. New York: McGraw-Hill Medical; 2008.
7.
Roger W, Cate W. Clinical Pharmacy
and therapeutics. 4th ed. London: Churchill Livingstone Co.;2007:377
8.
Ernst P,
Fitzgerald JM, Spier S. Canadian Asthma Consensus Conference: summary of
recommendations. Can Respir J, 1996; 3(2): 89-101.
9.
The British
guidelines on asthma management 1995: review and position statement. Thorax
1997;52(Suppl): S1-21
10.
Lewis RK, Lasack
NL, Lambert BL and Connor SE. Patient counselling – a focus on maintenance
therapy. Am J Health-Syst Pharm, 1997; 54(18):2084–98.
11.
P. Maheshwari, I.
Somasundaram. Health Related Quality of Life Measurement in Asthma and Chronic
Obstructive Pulmonary Disease. Research J. Pharm. and Tech. 2016; 9(5):
518-520.
12.
Pavithra H. Dave,
Preetha. Pathogenesis and Novel Drug for Treatment of Asthma – A Review.
Research J. Pharm. and Tech 2016; 9(9):1519-1523.
13.
SC Basak, D
Sathyanarayana. Evaluation of the Impact of an Educational Workshop for Community
Pharmacists. Research J. Pharm. and Tech. 2009; 2(1): 144-146
14.
Gandikota
Thanmayi, P Shanmugasundaram, P. Geetha. Role of Clinical Pharmacist in
Improving Patients Compliance including Risk Factors among Tuberculosis
Patients. Research J. Pharm. and Tech. 2017; 10(9): 2945-2948.
15.
Ayad M. Gaidan,
Ahmed A. Abbas, Mohammed A. Hassan, Hashem M. Hashim, Qasim S. Al-Mayah. The
Impact of IL-10 C-597A Gene Polymorphisms on Asthma Susceptibility. Research J.
Pharm. and Tech. 2017; 10(9): 2867-2870.
16.
Gandikota Thanmayi,
P Shanmugasundaram, P. Geetha. Role of Clinical Pharmacist in Improving
Patients Compliance including Risk Factors among Tuberculosis Patients.
Research J. Pharm. and Tech. 2017; 10(9): 2945-2948.
17.
Myoung-Hee Kim,
Mi Joon Lee. Level of Health-Related Quality of life (HRQoL) According to age
group among Korean adults. Research J. Pharm. and Tech 2018; 11(7): 2881-87.
18.
Hanna Panfilova,
Alla Nemchenko, Iuliia Korzh, Yuliya Zaytzeva, Natalia Bogdan, Oksana Tsurikova,
Liusine Simonian. Scientific Measurement of the Current Role of Pharmacist in
the Paradigm of Pharmaceutical Care Development. Research J. Pharm. and Tech
2019; 12(2):817-26.
19.
Shakeel Ahmed et
al. A Study on the Impact of
Pharmacist Mediated Patient Counselling On Quality Of Life in Asthma Patients”
at a Tertiary Care Hospital; RGUHS J Pharm Sci, 2013;3(2):57-64
20.
Benedicte
leynaert et al. Quality of Life in Allergic Rhinitis and Asthma A
Population-based Study of Young Adults. Am
J Respir Crit Care Med, 2000; 162(4 Pt 1):1391-96.
21.
Rathan Shyam M et
al. Role of clinical pharmacist in the impact of patient counselling in
asthmatic patients. J Glob Trends Pharm Sci, 2013; 4(2):1111-17
22.
K V Ramanath,
Nagakishore CH, Mahesh Kumar S, Balaji D B S S, Bhanuprakash M. A Study on
Medication Adherence & Quality of Life in Asthma & Chronic Obstructive
Pulmonary Diseases (COPD) of Rural Population in a Tertiary care Hospital. Indo
Glob J Pharm Sci, 2011; 1(4): 315- 27
23. Bowling A. Measuring Disease: A
Review of Disease-specific Quality of Life Measurement Scales (second edition). Qual
Life Res 2003 12(8): 1147-48
24.
Maille AR, Koning
CJ, Zwinderman AH, Willems LN, Dijkman JH, Kaptein AA. The development of the
‘Quality-of-life for Respiratory Illness Questionnaire (QOL-RIQ)’: a
disease-specific quality-of-life questionnaire for patients with mild to moderate
chronic non-specific lung disease. Respir Med. 1997; 91(5):297–309.
25.
Dalcin PT,
Grutcki DM, Laporte PP. Impact of a short-term educational intervention on
adherence to asthma treatment and on asthma control. J Bras Pneumol
2011;37(1):19-27
26.
Premaratne UN,
Sterne JA, Marks GB, Webb JR, Azima H, Burney PG. Clustered randomised trial of
an intervention to improve the management of asthma: Greenwich asthma study.
BMJ 1999; 318(7193):1251-55.
27.
Muhlhauser I,
Richter B, Kraut D, Weske G, Worth H, Berger M. Evaluation of a structured
treatment and teaching programme on asthma. J Intern Med. 1991;230(2):157–64
28.
Kheir N, Emmerton
L, Shaw J. Can pharmacists influence the health-related quality of life of
patients with asthma? The New Zealand Pharmaceutical Care experience. J Sci Res
Med Sci. 2001;3(2):69–75